Get the Stockscreener App
8.78
10.40%
-0.93
Regenxbio Inc Stock (RGNX) Forecast
The Regenxbio Inc (RGNX) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $14.29, representing a +62.81% increase from the current price of $8.78. The highest analyst price target is $19.34, and the lowest is $9.2516.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month RGNX Price Target
Average 14.42
(+64.23% Upside)
Is Regenxbio Inc (RGNX) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 49.85 | Neutral |
| STOCH(9,6) | 76.10 | Neutral |
| STOCHRSI(14) | 29.57 | Neutral |
| MACD(12,26) | 0.4403 | Buy |
| ADX(14) | 24.94 | Neutral |
| William %R | -51.83 | Neutral |
| CCI(14) | 24.65 | Neutral |
Buy: 1
Sell: 0
Neutral: 6
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
9.164
Sell
|
9.1521
Sell
|
| MA20 |
8.9225
Sell
|
8.8182
Sell
|
| MA50 |
7.9478
Buy
|
8.215
Buy
|
| MA100 |
7.6353
Buy
|
8.2155
Buy
|
| MA200 |
8.9783
Sell
|
9.5617
Sell
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, RGNX could be considered a Neutral, with 17 technical analysis indicators signaling 5 Buy signals, 6 signaling Sell signals and 6 Neutral signals. This suggests that investors should exercise caution when entering new positions on RGNX, as the market is likely to remain volatile in the near term.
- RSI (Relative Strength Index): The RSI(14) value of 49.85 indicates that RGNX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 76.1 indicates that RGNX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 29.57 indicates that RGNX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 24.94 suggests that there may be some movement in price, but it lacks strength or conviction.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of 24.65 indicates that RGNX is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.
Long-term RGNX price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Regenxbio Inc financial reports and earnings history, Regenxbio Inc (RGNX) stock could reach $12.18 by 2030, $24.45 by 2040 and $67.81 by 2050. See the projected annual prices until 2050 of the Regenxbio Inc stock below:
- Regenxbio Inc (RGNX) is expected to reach an average price of $5.0063 in 2035, with a high prediction of $10.16 and a low estimate of $5.5363. This indicates an $-42.98% rise from the last recorded price of $8.78.
- Regenxbio Inc (RGNX) stock is projected to chart a bullish course in 2040, with an average price target of $23.98, representing an $173.12% surge from its current level. The forecast ranges from a conservative $25.02 to a sky-high $24.45.
- Our analysts predict Regenxbio Inc (RGNX) to jump 400.49% by 2045, soaring from $41.78 to an average price of $43.94, potentially reaching $40.63. While $41.78 is the low estimate, the potential upside is significant.
- Regenxbio Inc (RGNX) stock is expected to climb by 2050, reaching an average of $64.20, a $631.26% jump from its current level. However, a wide range of estimates exists, with high and low targets of $67.81 and $66.98, respectively, highlighting the market's uncertainty.
Regenxbio Inc Stock (RGNX) Year by Year Forecast
Regenxbio Inc Stock (RGNX) Price Forecast for 2025
Regenxbio Inc Stock (RGNX) is expected to reach an average price of $14.28 in 2025, with a high prediction of $28.39 and a low estimate of $0.1691. This indicates an +62.66% rise from the last recorded price of $8.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| June, 2025 | $12.69 | $9.2516 | $19.34 | +44.55% |
| July, 2025 | $11.66 | $8.5397 | $18.90 | +32.85% |
| August, 2025 | $12.17 | $9.5387 | $14.95 | +38.64% |
| September, 2025 | $8.2503 | $7.9158 | $15.93 | -6.03% |
| October, 2025 | $3.9629 | $2.7729 | $10.43 | -54.86% |
| November, 2025 | $3.331 | $1.6715 | $6.0719 | -62.06% |
| December, 2025 | $4.8936 | $2.3955 | $6.1336 | -44.26% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2026
The predicted value for Regenxbio Inc (RGNX) in 2026 is set at an average of $15.26. Estimates vary from a peak of $27.17 to a trough of $3.3431, indicating an +73.75% surge from the present price of $8.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $13.44 | $3.3431 | $14.03 | +53.09% |
| February, 2026 | $21.59 | $10.98 | $22.60 | +145.90% |
| March, 2026 | $25.25 | $20.43 | $27.17 | +187.56% |
| April, 2026 | $20.45 | $17.30 | $26.67 | +132.92% |
| May, 2026 | $17.48 | $13.79 | $20.58 | +99.07% |
| June, 2026 | $12.92 | $9.7975 | $18.10 | +47.11% |
| July, 2026 | $14.21 | $9.5146 | $14.84 | +61.84% |
| August, 2026 | $16.01 | $11.71 | $16.97 | +82.31% |
| September, 2026 | $16.51 | $14.35 | $19.35 | +88.04% |
| October, 2026 | $10.16 | $9.7779 | $17.56 | +15.69% |
| November, 2026 | $11.47 | $5.9916 | $12.97 | +30.59% |
| December, 2026 | $21.41 | $11.78 | $25.82 | +143.83% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Regenxbio Inc (RGNX) is $12.27, with a high forecast of $23.90 and a low forecast of $0.6302. This indicates an +39.71% increase from the last price of $8.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $15.97 | $9.3576 | $23.90 | +81.85% |
| February, 2027 | $13.51 | $10.35 | $20.53 | +53.93% |
| March, 2027 | $12.87 | $9.2537 | $14.94 | +46.55% |
| April, 2027 | $8.5453 | $6.3853 | $16.74 | -2.67% |
| May, 2027 | $6.9434 | $4.8494 | $8.2044 | -20.92% |
| June, 2027 | $8.766 | $5.127 | $11.17 | -0.16% |
| July, 2027 | $14.61 | $7.005 | $16.03 | +66.45% |
| August, 2027 | $11.21 | $10.55 | $17.26 | +27.70% |
| September, 2027 | $3.7847 | $0.6302 | $11.73 | -56.89% |
| October, 2027 | $3.3528 | $1.4328 | $6.0583 | -61.81% |
| November, 2027 | $10.22 | $3.2923 | $10.93 | +16.41% |
| December, 2027 | $16.21 | $8.6155 | $18.51 | +84.66% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2028
In 2028, Regenxbio Inc (RGNX) is projected to reach an average price of $9.6634, with a high projection of $16.87 and a low estimate of $2.4542. This indicates an +10.06% rise from the last price of $8.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $12.72 | $11.79 | $16.87 | +44.89% |
| February, 2028 | $9.7896 | $5.4951 | $12.96 | +11.50% |
| March, 2028 | $7.3522 | $4.9787 | $10.50 | -16.26% |
| April, 2028 | $6.5503 | $3.5667 | $9.2467 | -25.40% |
| May, 2028 | $6.5129 | $5.5529 | $8.6093 | -25.82% |
| June, 2028 | $7.5209 | $5.9874 | $9.9964 | -14.34% |
| July, 2028 | $7.799 | $6.5805 | $9.0145 | -11.17% |
| August, 2028 | $5.7016 | $5.2766 | $10.36 | -35.06% |
| September, 2028 | $3.8297 | $3.1152 | $6.9219 | -56.38% |
| October, 2028 | $4.4978 | $2.4542 | $6.2578 | -48.77% |
| November, 2028 | $5.6603 | $2.8958 | $7.8768 | -35.53% |
| December, 2028 | $6.1884 | $4.4284 | $6.9584 | -29.52% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2029
The 2029 price forecast for Regenxbio Inc Stock (RGNX) is $9.0085 on average, with a high prediction of $17.71 and a low estimate of $0.3088. This represents an +2.60% increase from the previous price of $8.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $5.521 | $4.0115 | $6.7075 | -37.12% |
| February, 2029 | $4.9291 | $3.8946 | $6.3655 | -43.86% |
| March, 2029 | $4.8172 | $3.9672 | $5.8836 | -45.13% |
| April, 2029 | $3.3852 | $2.1307 | $5.2617 | -61.44% |
| May, 2029 | $5.4578 | $0.3088 | $5.8578 | -37.84% |
| June, 2029 | $7.5459 | $5.0123 | $8.6269 | -14.06% |
| July, 2029 | $6.084 | $5.864 | $9.3849 | -30.71% |
| August, 2029 | $0.7766 | $0.5266 | $6.8885 | -91.16% |
| September, 2029 | $6.1246 | $0.3511 | $8.9901 | -30.24% |
| October, 2029 | $10.82 | $5.8992 | $17.71 | +23.20% |
| November, 2029 | $4.9853 | $4.6153 | $11.52 | -43.22% |
| December, 2029 | $13.22 | $4.5398 | $6.4939 | +50.51% |
Regenxbio Inc Stock (RGNX) Price Forecast for 2030
Regenxbio Inc Stock (RGNX) is expected to reach an average price of $12.05 in 2030, with a high forecast of $23.31 and a low forecast of $0.7834. This signifies an +37.19% surge from the last price of $8.78.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $9.6748 | $12.24 | $12.18 | +10.19% |
| February, 2030 | $10.03 | $9.7148 | $9.8387 | +14.22% |
| March, 2030 | $16.00 | $9.6474 | $12.16 | +82.26% |
| April, 2030 | $22.32 | $21.32 | $21.31 | +154.23% |
| May, 2030 | $20.36 | $18.76 | $21.44 | +131.90% |
| June, 2030 | $14.95 | $18.20 | $16.56 | +70.22% |
| July, 2030 | $16.78 | $18.30 | $18.19 | +91.12% |
| August, 2030 | $12.84 | $14.36 | $12.17 | +46.28% |
| September, 2030 | $8.8176 | $14.08 | $12.31 | +0.43% |
| October, 2030 | $0.5126 | $3.5324 | $8.1905 | -94.16% |
| November, 2030 | $25.27 | $0.7834 | $14.48 | +187.77% |
| December, 2030 | $24.61 | $21.99 | $23.31 | +180.30% |
3.48%
1.26%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):